Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer
2602.2500 25.40 (0.99%)
NSE Mar 18, 2025 15:31 PM
Volume: 106.7K
 

logo
Ajanta Pharma Ltd.
01 May 2021
2602.25
0.99%
ICICI Securities Limited
Q4 revenues grew 11.0% YoY to | 757 crore. Domestic sales grew 23.2% to | 218 crore whereas emerging markets (branded) de-grew 10.5% YoY to | 273 crore amid logistical challenges in Asia and Africa. US sales grew 21% to | 173 crore. Africa tender business grew 86% YoY to | 80 crore. EBITDA margins improved significantly to 34.3% (vs. 22.2% in Q4FY20) amid better gross margins and lower other expenditure. EBITDA grew 71.4% YoY to | 259 crore. PAT grew 21% YoY to | 159 crore. Delta vis--vis EBITDA was...
Ajanta Pharma Ltd. has an average target of 2987.67 from 3 brokers.
More from Ajanta Pharma Ltd.
Recommended